Pfizer Inc. v. Breckenridge Pharmaceutical, Inc.
1:17-cv-00302
Overview
Case Number
1:17-cv-00302
Filing Date
2017-03-21
Status
Litigation filed
Court
District Court, D. Delaware
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, D. Delaware
Presiding Judge
Leonard Philip Stark
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Docket Entries
COMPLAINT FOR PATENT INFRINGEMENT filed against Breckenridge Pharmaceutical, Inc., Laboratorios del Dr. Esteve, S.A., Pensa Pharma S.A. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2106719.) - filed by Pfizer Inc., PF Prism C.V., C.P. Pharmaceuticals International C.V.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jcs) (Entered: 03/21/2017)
2017-03-21
1
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 03/21/2017)
2017-03-21
1
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/6/2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/6/2020. (jcs) (Entered: 03/21/2017)
2017-03-21
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,965,027 B2; 7,301,023 B2. (jcs) (Entered: 03/21/2017)
2017-03-21
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc for C.P. Pharmaceuticals International C.V., PF Prism C.V.: Pfizer Inc. has no parent corporation filed by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc. (jcs) (Entered: 03/21/2017)
2017-03-21
1
Summons Issued with Magistrate Consent Notice attached as to Breckenridge Pharmaceutical, Inc. on 3/21/2017; Laboratorios del Dr. Esteve, S.A. on 3/21/2017; Pensa Pharma S.A. on 3/21/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs)
2017-03-21
1
No Actions
Summons Issued
2017-03-21
1
No Actions
Case Assigned/Reassigned
2017-03-29
1
No Actions
Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
2017-03-29
1
No Actions
DECLARATION of Mailing (as to service on Breckenridge Pharmaceutical, Inc.) by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc.. (Attachments: # 1 Exhibit A & B)(Noreika, Maryellen) (Entered: 04/13/2017)
2017-04-13
1
STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to May 16, 2017 - filed by Breckenridge Pharmaceutical, Inc.. (Phillips, John) (Entered: 05/02/2017)
2017-05-02
1
SO ORDERED
2017-05-05
1
No Actions
SO ORDERED, re 7 STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to May 16, 2017 filed by Breckenridge Pharmaceutical, Inc. Signed by Judge Leonard P. Stark on 5/5/17. (ntl)
2017-05-05
1
No Actions
ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Breckenridge Pharmaceutical, Inc..(Phillips, John) (Entered: 05/16/2017)
2017-05-16
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pensa Pharma S.A. for Breckenridge Pharmaceutical, Inc. filed by Breckenridge Pharmaceutical, Inc.. (Phillips, John) (Entered: 05/16/2017)
2017-05-16
1
NOTICE of Appearance by Megan C. Haney on behalf of Breckenridge Pharmaceutical, Inc. (Haney, Megan) (Entered: 05/16/2017)
2017-05-16
1
MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli, Jeffrey Martin, Phillip Smithback, Stephanie Piper, Victoria L. Reines, and Soumitra Deka - filed by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc.. (Noreika, Maryellen) (Entered: 06/05/2017)
2017-06-05
1
ANSWER to 8 Answer to Complaint, Counterclaim by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc..(Noreika, Maryellen) (Entered: 06/06/2017)
2017-06-06
1
SO ORDERED
2017-06-06
1
No Actions
SO ORDERED, re (12 in 1:17-cv-00159-LPS, 14 in 1:17-cv-00158-LPS, 18 in 1:17-cv-00213-LPS, 11 in 1:17-cv-00302-LPS, 12 in 1:17-cv-00214-LPS) MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli, Jeffrey Martin, Phillip Smithback, Stephanie Piper, Victoria L. Reines, and Soumitra Deka filed by PF Prism C.V., C.P. Pharmaceuticals International C.V., Pfizer Inc. Signed by Judge Leonard P. Stark on 6/6/17. Associated Cases: 1:17-cv-00158-LPS, 1:17-cv-00159-LPS, 1:17-cv-00213-LPS, 1:17-cv-00214-LPS, 1:17-cv-00302-LPS (ntl)
2017-06-06
1
No Actions
Add Attorneys - PHV only
2017-06-09
1
No Actions
Pro Hac Vice Attorney Soumitra Deka, Stephanie M. Piper, Jeffrey Martin, Victoria L. Reines, Philip A. Smithback, and Aaron Stiefel for Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00158-LPS, 1:17-cv-00159-LPS, 1:17-cv-00213-LPS, 1:17-cv-00214-LPS, 1:17-cv-00302-LPS(ceg)
2017-06-09
1
No Actions
Add Attorneys - PHV only
2017-06-13
1
No Actions
Pro Hac Vice Attorney Daniel P. DiNapoli for C.P. Pharmaceuticals International C.V.,Daniel P. DiNapoli for PF Prism C.V.,Daniel P. DiNapoli for Pfizer Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00302-LPS, 1:17-cv-00158-LPS, 1:17-cv-00159-LPS, 1:17-cv-00213-LPS, 1:17-cv-00214-LPS(crb)
2017-06-13
1
No Actions
ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than September 11, 2017. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 8/25/17. Associated Cases: 1:17-cv-00158-LPS, 1:17-cv-00159-LPS, 1:17-cv-00213-LPS, 1:17-cv-00214-LPS, 1:17-cv-00302-LPS (ntl) (Entered: 08/25/2017)
2017-08-25
1
Order
2017-08-25
1
No Actions
STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to September 15, 2017 - filed by Breckenridge Pharmaceutical, Inc., Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) (Entered: 09/11/2017)
2017-09-11
1
SO ORDERED
2017-09-13
1
No Actions
SO ORDERED, re (16 in 1:17-cv-00158-LPS, 19 in 1:17-cv-00214-LPS, 15 in 1:17-cv-00159-LPS, 21 in 1:17-cv-00213-LPS, 14 in 1:17-cv-00302-LPS) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to September 15, 2017. Signed by Judge Leonard P. Stark on 9/13/17. Associated Cases: 1:17-cv-00158-LPS, 1:17-cv-00159-LPS, 1:17-cv-00213-LPS, 1:17-cv-00214-LPS, 1:17-cv-00302-LPS (ntl)
2017-09-13
1
No Actions
PROPOSED ORDER -- Scheduling Order -- by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc.. (Attachments: # 1 Letter to The Honorable Leonard P. Stark)(Noreika, Maryellen) (Entered: 09/15/2017)
2017-09-15
1
PROPOSED ORDER -- Scheduling Order -- by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc.. (Attachments: # 1 Letter to The Honorable Leonard P. Stark)(Noreika, Maryellen) (Entered: 09/15/2017)
2017-09-15
2
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 1/18/2019. Status Report due by 8/29/2018. Claim Construction Opening Brief due by 6/8/2018. Claim Construction Answering Brief due by 7/13/2018. A Markman Hearing is set for 8/27/2018 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 4/20/2020. A Final Pretrial Conference is set for 5/1/2020 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 5-day Bench Trial is set for 5/11/2020 at 08:30 AM before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 9/20/17. Associated Cases: 1:17-cv-00158-LPS, 1:17-cv-00159-LPS, 1:17-cv-00213-LPS, 1:17-cv-00214-LPS, 1:17-cv-00302-LPS (ntl) (Entered: 09/21/2017)
2017-09-21
1
CASE REFERRED to Magistrate Judge Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00158-LPS, 1:17-cv-00159-LPS, 1:17-cv-00213-LPS, 1:17-cv-00214-LPS, 1:17-cv-00302-LPS(dlb)
2017-09-21
1
No Actions
Case Referred to Mediation - Magistrate Judge only
2017-09-25
1
No Actions
Oral Order
2017-09-25
1
No Actions
ORAL ORDER: In light of the District Court's ADR referral in this case, and the number of parties involved in this matter and related cases, the Court orders as follows: Plaintiff(s) counsel shall contact counsel for each defendant to discuss whether both sides believe that the Court's assistance with settlement discussions would be helpful at some point in the case. If both plaintiff(s) and an individual defendant believe that the case has reached a stage whereby the Court's assistance is needed with regard to settlement, plaintiff(s) counsel shall contact the Court to schedule an ADR Teleconference for plaintiff and that individual defendant. Ordered by Judge Christopher J. Burke on 9/25/2017. Associated Cases: 1:17-cv-00158-LPS, 1:17-cv-00159-LPS, 1:17-cv-00213-LPS, 1:17-cv-00214-LPS, 1:17-cv-00302-LPS(dlb)
2017-09-25
1
No Actions
NOTICE OF SERVICE of Plaintiffs' Fed. R. Civ. P. 26(a) Initial Disclosure Statement filed by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc..(Noreika, Maryellen) (Entered: 09/29/2017)
2017-09-29
1
NOTICE OF SERVICE of Defendant Breckenridge Pharmaceuticals, Inc.'s Initial Disclosures filed by Breckenridge Pharmaceutical, Inc..(Haney, Megan) (Entered: 09/29/2017)
2017-09-29
1
NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc..(Noreika, Maryellen) (Entered: 10/11/2017)
2017-10-11
1
NOTICE OF SERVICE of Defendant Breckenridge Pharmaceutical, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Breckenridge Pharmaceutical, Inc..(Haney, Megan) (Entered: 10/11/2017)
2017-10-11
1
STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to November 1, 2017 - filed by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc.. (Noreika, Maryellen) (Entered: 10/18/2017)
2017-10-18
1
NOTICE OF SERVICE of Plaintiffs' Identification of Accused Product and Asserted Patents filed by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc..(Noreika, Maryellen) (Entered: 10/18/2017)
2017-10-18
1
SO ORDERED
2017-10-20
1
No Actions
SO ORDERED, re (23 in 1:17-cv-00158-LPS, 21 in 1:17-cv-00302-LPS, 22 in 1:17-cv-00159-LPS, 26 in 1:17-cv-00214-LPS, 28 in 1:17-cv-00213-LPS) STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to November 1, 2017 filed by PF Prism C.V., C.P. Pharmaceuticals International C.V., Pfizer Inc. Signed by Judge Leonard P. Stark on 10/20/17. Associated Cases: 1:17-cv-00158-LPS, 1:17-cv-00159-LPS, 1:17-cv-00213-LPS, 1:17-cv-00214-LPS, 1:17-cv-00302-LPS (ntl)
2017-10-20
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Robert Vroom - filed by Breckenridge Pharmaceutical, Inc.. (Attachments: # 1 Certification of Robert Vroom)(Phillips, John) (Entered: 10/27/2017)
2017-10-27
1
SO ORDERED
2017-10-31
1
No Actions
SO ORDERED, re 23 MOTION for Pro Hac Vice Appearance of Attorney Robert Vroom filed by Breckenridge Pharmaceutical, Inc. Signed by Judge Leonard P. Stark on 10/31/17. (ntl)
2017-10-31
1
No Actions
PROPOSED ORDER -- Stipulated Protective Order -- by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc.. (Noreika, Maryellen) (Entered: 11/01/2017)
2017-11-01
1
SO ORDERED, re (28 in 1:17-cv-00214-LPS, 24 in 1:17-cv-00302-LPS, 24 in 1:17-cv-00159-LPS, 26 in 1:17-cv-00158-LPS, 30 in 1:17-cv-00213-LPS) STIPULATED PROTECTIVE ORDER. Signed by Judge Leonard P. Stark on 11/6/17. Associated Cases: 1:17-cv-00158-LPS, 1:17-cv-00159-LPS, 1:17-cv-00213-LPS, 1:17-cv-00214-LPS, 1:17-cv-00302-LPS (ntl)
2017-11-06
1
No Actions
SO ORDERED
2017-11-06
1
No Actions
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding request for teleconference. (Noreika, Maryellen) (Entered: 11/13/2017)
2017-11-13
1
NOTICE OF SERVICE of Defendant Breckenridge Pharmaceutical, Inc.'s Production of Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Breckenridge Pharmaceutical, Inc..(Haney, Megan) (Entered: 11/20/2017)
2017-11-20
1
ORAL ORDER: IT IS HEREBY ORDERED that a Telephone Conference is set for 11/28/2017 at 03:00 PM. Counsel for Plaintiffs shall initiate the call to (302) 573-4571. A status report is due on 11/27/17. ORDERED by Judge Leonard P. Stark on 11/20/17. Associated Cases: 1:17-cv-01532-LPS et al. (ntl) (Entered: 11/20/2017)
2017-11-20
1
Order Setting Teleconference
2017-11-20
1
No Actions
Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding status - re (26 in 1:17-cv-00159-LPS, 29 in 1:17-cv-00158-LPS, 9 in 1:17-cv-01597-LPS, 33 in 1:17-cv-00213-LPS, 8 in 1:17-cv-01532-LPS, 27 in 1:17-cv-00302-LPS, 31 in 1:17-cv-00214-LPS) Order Setting Teleconference,. (Noreika, Maryellen) (Entered: 11/27/2017)
2017-11-27
1
Pro Hac Vice Attorney Robert F. Vroom for Breckenridge Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-11-28
1
No Actions
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 11/28/2017. (Court Reporter B. Gaffigan.) Associated Cases: 1:17-cv-00158-LPS et al. (ntl)
2017-11-28
1
No Actions
Add Attorneys - PHV only
2017-11-28
1
No Actions
Telephone Conference
2017-11-28
1
No Actions
Official Transcript of Telephone Conference held on November 28, 2017 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/28/2017. Redacted Transcript Deadline set for 1/8/2018. Release of Transcript Restriction set for 3/7/2018.(bpg) (Entered: 12/07/2017)
2017-12-07
1
NOTICE OF SERVICE of (1) Plaintiffs' First Set of Common Interrogatories to Defendants; (2) Plaintiffs' First Set of Requests to Micro Labs USA Inc. and Micro Labs, Ltd. for the Production of Documents and Things; (3) Plaintiffs' First Set of Requests to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. for the Production of Documents and Things; (4) Plaintiffs' First Set of Requests to Prinston Pharmaceutical Inc. for the Production of Documents and Things; (5) Plaintiffs' First Set of Requests to Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. for the Production of Documents and Things; and (6) Plaintiffs' First Set of Requests to Breckenridgeg Pharmaceutical, Inc., Pensa Pharma S.A., and Laboratorios Del Dr. Esteve, S.A. for the Production of Documents and Things filed by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc., Pfizer PFE Ireland Pharmaceuticals Holding 1 Cooperatief U.A., Pfizer Pharmaceuticals LLC.(Noreika, Maryellen) (Entered: 12/19/2017)
2017-12-19
1
STIPULATION and Order (regarding consolidation) by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc., Pfizer PFE Ireland Pharmaceuticals Holding 1 Cooperatief U.A., Pfizer Pharmaceuticals LLC. (Noreika, Maryellen) (Entered: 12/20/2017)
2017-12-20
1
SO ORDERED, re (16 in 1:17-cv-01532-LPS, 38 in 1:17-cv-00213-LPS, 31 in 1:17-cv-00302-LPS, 35 in 1:17-cv-00214-LPS, 33 in 1:17-cv-00158-LPS, 16 in 1:17-cv-01597-LPS, 30 in 1:17-cv-00159-LPS) Stipulation and Order to Consolidate for All Purposes. All filings shall be made in Civil Action No. 17-158-LPS. Signed by Judge Leonard P. Stark on 12/22/17. Associated Cases: 1:17-cv-00158-LPS et al. (ntl)
2017-12-22
1
No Actions
Case associated with lead case: Create association to 1:17-cv-00158-LPS. (ntl)
2017-12-22
1
No Actions
Create Case Association - dkt in member case for Consol or MDL
2017-12-22
1
No Actions
SO ORDERED
2017-12-22
1
No Actions
STIPULATION of Dismissal (between Plaintiffs and Breckenridge Pharmaceutical, Inc.) by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc., Pfizer PFE Ireland Pharmaceuticals Holding 1 Cooperatief U.A., Pfizer Pharmaceuticals LLC. (Noreika, Maryellen) (Entered: 06/04/2018)
2018-06-04
1
NOTICE of Voluntary Dismissal by C.P. Pharmaceuticals International C.V., PF Prism C.V., Pfizer Inc., Pfizer PFE Ireland Pharmaceuticals Holding 1 Cooperatief U.A., Pfizer Pharmaceuticals LLC as to defendants Pensa Pharma S.A. and Laboratorios Del Dr. Esteve, S.A. (Noreika, Maryellen) (Entered: 06/04/2018)
2018-06-04
1
SO ORDERED, re (17 in 1:17-cv-01532-LPS, 32 in 1:17-cv-00302-LPS) Stipulation of Dismissal as to Breckenridge Pharmaceutical, Inc. Signed by Judge Leonard P. Stark on 6/6/18. Associated Cases: 1:17-cv-00302-LPS, 1:17-cv-01532-LPS (ntl)
2018-06-06
1
No Actions
CASE CLOSED (ntl)
2018-06-06
1
No Actions
Order Setting Mediation Conferences
2020-01-23
1